CBLB and melanoma: Without Cbl-b, PD-1 is inefficient in suppressing IFN-γ production or inducing cell death upon T-cell activation, and Cbl-b−/− mice are capable of rejecting melanoma tumors that escape immune response in wild-type mice via PD-1 signaling [135].